Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

S2Medical wins procurement for wound healing items in the United Arab Emirates worth approximately SEK 3.4 million

S2Medical AB (publ) (the "Company") has, via the Company's local partner in the United Arab Emirates, won a procurement for wound healing items within Mubadala Health LLC. The value of the procurement is estimated at approximately SEK 1.7 million per year for at least 2 years, a total of approximately SEK 3.4 million. Mubadala Health has announced that they intend to call off the procurement quarterly with orders corresponding to approximately SEK 400,000 - 500,000.   Mubadala Health is part of the Mubadala Investment Company and is one of the UAE's largest healthcare providers.

First section of Tokmanni’s new logistics centre now in operation – Centralizing Tokmanni’s logistics operations in Mäntsälä will modernise and streamline its logistics and supply chain

Tokmanni     Press release     21 April 2023 at 4:30 p.m. The new logistics centre currently under construction in Mäntsälä is a very significant investment for Tokmanni. It will help the company to modernise and streamline its logistics and supply chain. Lots of orange shelves. Long corridors. Dozens of Tokmanni employees and loads of lorries – including the familiar red Tokmanni lorries – are coming and going. The first section of Tokmanni’s new logistics centre has now been handed over by the contractor. The new centre, next door to Tokmanni’s existing administration and

Bulletin from the Annual General Meeting of John Mattson Fastighetsföretagen AB (publ)

At the annual general meeting (the “AGM”) of John Mattson Fastighetsföretagen AB (publ) held on 21 April 2023, the annual accounts for the financial year 2022 were adopted, it was resolved that no dividend shall be paid, the board members and CEO were discharged from liability for the 2022 financial year, it was resolved to amend the articles of association and the board of directors were authorised to issue shares.The AGM resolved not to distribute any dividend for the 2022 financial year and that the funds available for appropriation by the AGM, approximately SEK 1,833 million, be carried

Arctic Bioscience – Approval of share capital increase

Reference is made to the stock exchange release published by Arctic Bioscience earlier today 21 April 2023 regarding minutes from the Annual General Meeting.The Annual General Meeting resolved to increase the share capital from NOK 2 442 571,90 to NOK 2 536 955,20 by subscription of 943 833 new shares with a nominal value of NOK 0,10 per share, at a subscription price of NOK 17,27 per share, including a share premium of NOK 17,17 per share. The new shares shall be subscribed by Ronja Capital II AS and the subscription amount shall be settled by set off against the subscriber’s claim on

Epidemic Sound Artists Soundtrack the UN’s 17 Global Goals

· Epidemic Sound and Heart 17 continues partnership for the second consecutive year with the goal of spreading awareness around the UN’s 17 Global Goals · Today, on the UN World Creativity and Innovation Day, Epidemic Sound launches 17 songs for the Global Goals in partnership with the global initiative Heart 17 · To support and help raise awareness of the initiative, 19 Epidemic Sound artists, such as Ebo Krdum and Anna Landström, have created original tracks for the 17 Global GoalsStockholm, Sweden – Epidemic Sound, the market-leading music licensing platform for content creators,

Step into the House of AI at Berghs Festival 2023

Berghs School of Communication proudly announces “House of AI” to unite people and AI under one roof in a symbiotic relationship. It marks the return of the Student Agency after a four-year hiatus. This festival of ideas and creativity, created by a 12-member in-house agency, is set to take place on the 26th and 27th of May.[pressbild studentbyrn] First row from the left: Alva Saveby, Peyvand Ahmedi, William Andersson, Clara-Corina Imre, Charlotte Källström, Julia Löfqvist, Emma Schlyter, Li Wall, Noa Carle & Stella Nylén. Not in picture: Linn Berghagen Nilsson & Antonia Rösch.

Publication of Raute Corporation’s Q1 2023 Interim Report and invitation to a briefing

Raute Corporation, Investor news, 21 April 2023 Publication of Raute Corporation’s Q1 2023 Interim Report and invitation to a briefing   Raute Corporation will publish its Interim Report for January 1−March 31, 2023 (3 months) on Friday, April 28, 2023 at about 8 a.m. Finnish time. A briefing for analysts, investors and the media will be organized on the same day April 28, 2023 at 10:00−11:00 a.m.   Venue: Scandic Simonkentta Hotel, Simonkatu 9, Helsinki.   Please inform of your participation in the briefing at the latest on Wednesday, April 26, 2023 to Raute

Neste supplies sustainable aviation fuel to Air Canada for flights from San Francisco International Airport

Neste Corporation, News, 21 April 2023  Photo: courtesy of Air CanadaNeste and Air Canada are expanding their collaboration with an additional supply of 2.5 million gallons (9.5 million liters or 7,500 tons) of Neste MY Sustainable Aviation Fuel™ . The sustainable aviation fuel (SAF) supplied to Air Canada will be blended with conventional jet fuel and used to power the airline’s flights from the San Francisco International Airport.Air Canada has committed to the ambitious goal of net-zero emissions from all its global operations

Resqunit and Sig Hansen with a successful product demo in Norway - launching the product globally

On Thursday 20th April, Resqunit conducted a successful product demo during "One Ocean Week" in Bergen, Norway. The demo was made by major shareholder and the world's most famous fisherman and captain, Sig Hansen.STOCKHOLM, April 21, 2023, 14:30 CET - Resqunit AB (Nasdaq First North GM: RESQ) - We are very proud and satisfied to have carried out this exclusive product demo of our new product which is now being launched in several countries. The fight against ghost fishing has been going on for a long time, but with this product we can now begin to see the end. Our solution helps reduce a

GomSpace announces outcome of completed rights issue

GomSpace Group AB (publ) ("GomSpace" or the "Company") hereby announces the outcome of the rights issue of new shares resolved by the board of directors on 17 March 2023, with support of the authorisation from the annual general meeting held on 22 April 2022 (the "Rights Issue"). In total, 77,939,396 new shares, corresponding to approximately SEK 101 million or approximately 83 percent of the Rights Issue, have been subscribed for with and without subscription rights of which 41,225,646 new shares have been subscribed for against payment through set-off of the convertible loan of

GomSpace offentliggör utfall i genomförd företrädesemission

GomSpace Group AB (publ) (”GomSpace” eller ”Bolaget”) offentliggör härmed utfallet i den företrädesemission av nya aktier som beslutades av styrelsen den 17 mars 2023 med stöd av bemyndigande från årsstämman den 22 april 2022 (”Företrädesemissionen”). Totalt har 77 939 396 nya aktier, motsvarande cirka 101 MSEK eller cirka 83 procent av Företrädesemissionen, tecknats med och utan stöd av teckningsrätter varav 41 225 646 nya aktier har tecknats mot betalning genom kvittning av det konvertibla lånet om cirka 53,6 MSEK i enlighet med de teckningsåtaganden som beskrivs i det prospekt som

Immedica’s partner OrphanPacific initiates phase 3 trial with glycerol phenylbutyrate for treatment of urea cycle disorders in Japan

Stockholm, April 21 , 2023 - Immedica’s partner OrphanPacific Inc. (Tokyo, Japan) has enrolled the first patient in the phase 3 clinical trial with glycerol phenylbutyrate for the treatment of urea cycle disorders (UCD) in Japan. Immedica’s CEO Anders Edvell commented: “There is a significant medical need for better treatment options for people living with urea cycle disorders around the world. The initiation of this trial is a significant step towards expanding access to glycerol phenylbutyrate for patients in Japan.” This phase 3 clinical trial is planned to enroll 15 pediatric and

UNION therapeutics to participate at Kempen Life Science Conference

Hellerup, Denmark, April 21, 2023 – UNION therapeutics A/S (UNION), a privately-held, multi-asset, clinical stage, pharmaceutical development company focused on immunology and infectious disease, today announced participation at the Kempen Life Science Conference on April 25-26, 2023, in Amsterdam.   Contacts Morten Boesen, Chief Financial Officer, UNION therapeutics A/S +45 2381 5487 morten.boesen@uniontherapeutics.com   Sarah Toft-Jørgensen, Director of Communications and IR, UNION therapeutics A/S +45 5385 3044 stj@uniontherapeutics.com   About UNION

Aker Horizons ASA: Minutes of Annual General Meeting

The 2023 Annual General Meeting of Aker Horizons ASA was held today as a digital meeting with online participation.All resolutions were made in accordance with the proposals set out in the meeting notice. Minutes of the meeting are attached and available on https://akerhorizons.com/investors/shareholder-center/annual-general-meeting/. The general meeting elected six shareholder-appointed directors to the board. Øyvind Eriksen and Lone Fønss Schrøder were re-elected in their current positions for a period of two years. Lene Landøy was re-elected as deputy for a period of one year, and

Lantmännen updates MTN programme and publishes Prospectus, 2023

The Board of Directors of Lantmännen ek for ("Lantmännen") has decided to update its Medium Term Note programme (the "MTN programme"). Due to the MTN programme, Lantmännen's Board of Directors has prepared a base prospectus. The Swedish Financial Supervisory Authority has today, 21 April 2023, approved and registered the base prospectus.The MTN programme provides a framework within which Lantmännen can raise loans in SEK or EURO with a maturity of at least one year within a maximum outstanding nominal amount of SEK 3 billion, or the equivalent thereof in euros, at any given time. The

Read original

Invitation to presentation of Q1 2023

Concordia Maritime invites to teleconference/audio transmission on 4 May 2023 at 16.00 CEST. The session will feature a presentation of the Q1 2023 interim report and a Q&A session.If you wish to participate via webcast, please use the link below. Via the webcast you are able to ask written questions. https://ir.financialhearings.com/concordia-maritime-q1-2023 If you wish to participate via teleconference, please register on the link below. After registration you will be provided phone numbers and a conference ID to access the conference. You can ask questions verbally via the

Norse Atlantic ASA: Mandatory notifications of trade of close associates

21 April 2023: Reference is made to the stock exchange notice by Norse Atlantic ASA (the "Company") on 20 April 2023 regarding the completion of the subsequent offering of 60,000,000 new shares in the Company (the "Subsequent Offering"), at a subscription price of NOK 2.50 per share (the "Offer Price").Vineta Ltd, a company wholly owned by Terje Bodin Larsen, chairperson of the board of directors of the Company, was allocated 200,000 shares in the Subsequent Offering at the Offer Price. Following the transaction, Terje Bodin Larsen and related parties will control 300,000 shares in the

#23-33 Extended evening Trading Hours for ETPs until 22:00 CET

Nordic Growth Market (NGM) is an innovative Stock Exchange that continuously leads the development of the Nordic ETP market. As the first Exchange in the Nordics, NGM is pleased to offer investors extended evening trading hours until 22:00 CET as from May 2, 2023. The change is applicable for NGM’s ETP markets in Sweden, Finland, Norway and Denmark.  Commencing May 2, Post Open is changed to 22:00 CET and Closed is changed to 22:15 CET. Pre Open and start of Continuous Trading will remain unchanged from the current schedule. The evening trading schedule changes in the specified market

ChromoGenics postpones Annual General Meeting and delivery and publication of the Annual Report for 2022

The Board of Directors of ChromoGenics has decided to postpone the Annual General Meeting and the delivery and publication of the Annual Report for 2022.For practical reasons, the Board of Directors of ChromoGenics has decided to postpone the Annual General Meeting until the 27[th] of June 2023 as well as the publication of the Annual Report for 2022 until the 6[th] of June 2023. Previously communicated date for the Annual General Meeting was the 25[th] of May 2023 and the 27[th] of April 2023 for the Annual Report for 2022.

Kallelse till årsstämma i BPC Instruments AB / Notice to the Annual General Meeting in BPC Instruments AB

Aktieägarna i BPC Instruments AB, org.nr. 556687-2460, kallas härmed till årsstämma torsdagen den 25 maj 2023 kl. 16:00, Mobilvägen 4-6 (EATERY-restaurangen på bottenplan), 223 62 Lund och även digitalt via LegiMeet. / The shareholders of BPC Instruments AB, reg.no. 556687-2460, are hereby invited to attend the Annual General Meeting on Thursday, May 25th, 2023 at 4 p.m., Mobilvägen 4-6 (the EATERY restaurant area at ground floor), 223 62 Lund and digitally by LegiMeet.N.B. The English text is an unofficial translation of the notice to the Annual General Meeting in BPC Instruments AB,

Invitation to web presentation of Formpipe’s Q1 report 2023.

Formpipe will publish its interim report for the first quarter 2023 on Wednesday 26 April 2023 at 08:45 (CEST).The same day at 10:00 (CET), Formpipe’s President and CEO Christian Sundin will host a web presentation in English which is webcasted live on: https://www.formpipe.com/en/q12023, where it also will be available on demand shortly afterwards. Following the presentation, Christian Sundin, and Joakim Alfredson CFO, will be available to answer questions. The report and presentation will be available at: www.formpipe.com/en/investors/reports-and-presentations Welcome!

ExpreS2ion resolves on a directed issue of units to guarantors in connection with the completed rights issue

NOT FOR RELEASE, DISTRIBUTION OR PUBLICATION IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, WITHIN OR TO THE UNITED STATES, AUSTRALIA, CANADA, HONG KONG, JAPAN, NEW ZEALAND, SOUTH AFRICA, SOUTH KOREA, SWITZERLAND OR IN ANY OTHER JURISDICTION WHERE SUCH RELEASE, DISTRIBUTION OR PUBLICATION WOULD BE UNLAWFUL OR WOULD REQUIRE REGISTRATION OR ANY OTHER MEASURES. Hørsholm, Denmark, 21 April 2023 - The Board of Directors of ExpreS2ion Biotech Holding AB (publ)  ("ExpreS2ion" or the "Company") has today, on 21 April 2023, based on the authorisation from the Annual General Meeting on 25 May 2022,

There are no items matching the current filter
There are no more items matching the current filter
Back to top